Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

“…(G) <i>klf2a</i> expression decreases after 15-h lidocaine treatment (90%, <i>n</i> = 67). …”

Supplementary Material for: Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease by Watanabe N. (4118812)

“…At baseline, median hsTnI was 1.9 pg/mL and ranged from 0 to 69.6 pg/mL. Five patients (3.5%) had a high hsTnI value that exceeded 26.2 pg/mL, which is used as the cutoff for diagnosis of myocardial infarction, and 22 patients (15.4%) had an intermediate value between 5.0 and 26.2 pg/mL. …”

Reduced follicles, decreased ovulation and decreased fertilization of female Meox-2-cre/Separase S1121A mutant mice. by Juan Xu (225010)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

The decrease in blood flow disrupts CV pruning. by Lin Wen (557398)

SDG decreases iron-induced apoptosis in H9c2 cells. by Stephanie Puukila (568109)

Decreasing pixel differences caused by worm movement correspond to decreasing locomotive health. by Areta Jushaj (8525655)

SDG decreases iron-induced oxidative stress in H9c2 cells. by Stephanie Puukila (568109)

of decreased GFR by age and gender. by Hui Song (53547)

Subjects:

Resveratrol decreases PKM2 expression. by Mohd Askandar Iqbal (324124)

Subjects:

Pretreatment with SDG prevents iron induced decrease in H9c2 cell size. by Stephanie Puukila (568109)

SDG decreases iron-induced MMP gene expression in H9c2 cells. by Stephanie Puukila (568109)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Decreasing cell adhesion decreases [Ca²⁺]_i oscillation frequency. by Charles Godbout (540424)

Silencing of Rap1A decreases ERK and p38 activation. by Yougen Wu (830191)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

Subjects:

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

DMB treatment decreased neuronal apoptosis in cerebral ischemia. by Huinan Zhang (849524)

PSD-95 decreased ASIC2a acid-evoked current. by Anne Marie S. Harding (546425)

Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

Subjects: